Gordon Murdo's Form 4 filing
Amgen Inc (AMGN) · filed Feb 13, 2025
- Accession no.
- 0001127602-25-004776
- Filed
- Feb 13, 2025
- Trade date
- Feb 11, 2025
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not checked
This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market sales total $2.59M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Gordon MurdoCIK 0001642156 | Officer (EVP, Global Commercial Ops) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 11, 2025 | Common Stock | SSaleDisposed | −8,771 | $294.79 | −$2,585,603.09 | 44,186 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.